Phase 3 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a Chinese woman aged 65 or younger
- You have been diagnosed with an ovarian stromal tumor (a specific type of ovarian tumor), confirmed by a tissue sample, including types such as granulosa cell tumor, Sertoli-Leydig cell tumor, or other related types (confirm with trial site for full list)
- Your cancer has been newly diagnosed and is at a moderately advanced to advanced stage (stage IIA through IVB)
- You have had surgery related to your diagnosis within the past 8 weeks
- Your blood counts and organ function (liver, kidneys, and blood cells) meet certain healthy levels as measured by lab tests (confirm with trial site for specific values)
- You are well enough to carry out daily activities at a reasonable level, as measured by a standard health scoring system
- You are willing and able to sign a written consent form agreeing to take part
Who may not be able to join:
- You have a serious or poorly controlled medical condition that makes surgery or chemotherapy unsafe for you
- You have had an organ transplant or have a history of immune system disease
- You have a history of serious mental illness or a condition affecting brain function
- You have a history of drug misuse or substance abuse
- You currently have or have previously had another type of cancer
- You are currently taking part in another clinical trial
- You are unwilling or unable to sign the consent form
- You are unwilling or unable to follow the rules and schedule of the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Beihua Kong, MD. PhD., Qilu Hospital of Shandong University
Phone: +8618560081888
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.